Literature DB >> 7808975

Two-year-old boy with Proteus syndrome and fatal pulmonary thromboembolism.

D A Eberhard1.   

Abstract

A 2-year-old boy with a relatively mild form of Proteus syndrome (PS) died suddenly during a previously uncomplicated postsurgical convalescence. Autopsy demonstrated massive acute pulmonary embolism, which has not been previously reported in PS. In addition, clinically occult mesodermal hamartomata, predominantly hemolymphangiomata, were found to be widespread in the pelvoabdominal viscera, including spleen, appendix, kidneys, adrenal gland, liver, and retroperitoneal soft tissues. Such lesions may well be common in PS patients but may not be detected by conventional radiographic imaging techniques unless they are fairly large.

Entities:  

Mesh:

Year:  1994        PMID: 7808975     DOI: 10.3109/15513819409037674

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  5 in total

1.  Characterization of thrombosis in patients with Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay N Lozier; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2017-06-19       Impact factor: 2.802

Review 2.  Pulmonary thromboembolism in children.

Authors:  Paul S Babyn; Harpal K Gahunia; Patricia Massicotte
Journal:  Pediatr Radiol       Date:  2005-01-06

3.  Prophylactic anticoagulation of individuals with Proteus syndrome and COVID-19.

Authors:  Christopher A Ours; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2020-09-10       Impact factor: 2.578

4.  Quantifying survival in patients with Proteus syndrome.

Authors:  Julie C Sapp; Lian Hu; Jean Zhao; Ashlyn Gruber; Brian Schwartz; Dora Ferrari; Leslie G Biesecker Md
Journal:  Genet Med       Date:  2017-06-29       Impact factor: 8.822

5.  Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay Lozier; Neal Oden; Anjali Taneja; Jasmine Burton-Akright; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-09-06       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.